This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial (FMRIMetSynd)

This study has been withdrawn prior to enrollment.
(Funding for the study was not received. No recruitment ever occurred.)
Sponsor:
Collaborators:
Mountain States Group
Saint Alphonsus Medical Group
Quantified, Inc.
Information provided by (Responsible Party):
Family Medicine Residency of Idaho
ClinicalTrials.gov Identifier:
NCT01839864
First received: April 18, 2013
Last updated: February 13, 2017
Last verified: February 2017
  Purpose
The study aims are to test whether the use of promotoras significantly impacts the health attitudes, health seeking behaviors, and patient confidence in self-managing health of rural Hispanic adults who have been diagnosed with metabolic syndrome. Specifically, the study is designed to address four areas of inquiry: 1) identification of patient attitudes involving: a) trust in medical providers and in the health care system, b) procedural fairness in treatment, c) provider and patient communication patterns, d) potential cultural bias in treatment, and e) healthy lifestyle behavior adoption/maintenance, 2) selected clinical indicators of metabolic syndrome (blood pressure, height/weight/BMI, blood glucose, hemoglobin A1c, and cholesterol), 3) the cultural competence of medical providers from the perspective of both the provider and the patient, and 4) patient self-management confidence scores.

Condition Intervention
Metabolic Syndrome Behavioral: Promotora plus standard physical screening exam , hemoglobin A1c levels, lipid panels, fasting glucose, height, weight, BMI, Complete Blood Count

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Care Provider, Investigator, Outcomes Assessor
Primary Purpose: Treatment
Official Title: Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial

Resource links provided by NLM:


Further study details as provided by Family Medicine Residency of Idaho:

Primary Outcome Measures:
  • Change in Patient Activation Measure from baseline to six months and six months to one year [ Time Frame: study entry, six months, one year ]
    The patient activation measure (PAM), developed by Hibbard and colleagues, measures patient activation, which has been described as involving four sequential stages: 1) patients believe they have an important role in managing their health, 2) patients possess the necessary knowledge to manage their health, 3) patients take both behavioral and skill-based action to maintain their health, and 4) patients manage their health as best possible under most any circumstance or change in health condition.22 It consists of a 13 item questionnaire which asks respondents to answer "strongly agree", "agree", "disagree" or "strongly disagree" to each item. Scores indicate which of the four stages the respondent is in.


Secondary Outcome Measures:
  • Changes in patient attitudes about providers and carefrom baseline to six months and six months to one year [ Time Frame: study entry, six months, and one year ]
    An attitudinal qualitative measures instrument has been derived from a variety of studies, instruments, and theories. The instrument, which features a series of directional attitude statements, consists of 23 statements all of which have Likert Scale response categories "strongly agree", "agree", "disagree", "strongly disagree", and "have not considered". Each of the perspectives/attitudes patients and providers planning this study desired to be measured is reflected in the instrument, i.e., trust in medical providers and the health care system, attitudes about procedural fairness in health care treatment, comfort with seeking care in the health care system, attitudes about communication patterns between physicians and patients, and potential feelings of cultural treatment bias against minorities. The statements are scrambled so that respondents will not pick up a pattern, and attitude perception scores are tallied by combining scores from like items.


Other Outcome Measures:
  • Changes in sequelae associated with metabolic syndrome from baseline to six months and six months to one year [ Time Frame: study entry, six month and one year ]

    A reduction in sequelae associated with metabolic syndrome

    1. Fewer patients will become diabetic
    2. Fewer heart attacks and strokes


Enrollment: 0
Study Start Date: September 2013
Estimated Study Completion Date: August 2016
Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Promotora plus standard care model
Promotora plus standard physical screening exam, hemoglobin A1c levels, lipid panels, fasting glucose, height, weight, BMI, Complete Blood Count
Behavioral: Promotora plus standard physical screening exam , hemoglobin A1c levels, lipid panels, fasting glucose, height, weight, BMI, Complete Blood Count
Promotora services plus the standard care model will be provided for one randomly assigned cohort of patients meeting the inclusion criteria while the other cohort will receive the standard care model only

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult
  • Rural dwelling Hispanics who have been diagnosed with metabolic syndrome

Exclusion Criteria:

  • All others
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01839864

Locations
United States, Idaho
Saint Alphonsus Medical Group Caldwell Clinic
Caldwell, Idaho, United States, 83605
Saint Lukes Clinic Jerome
Jerome, Idaho, United States, 83338
St Alphonsus Medical Group Nampa Clinic
Nampa, Idaho, United States, 83686
Sponsors and Collaborators
Family Medicine Residency of Idaho
Mountain States Group
Saint Alphonsus Medical Group
Quantified, Inc.
Investigators
Principal Investigator: James T Girvan, PhD, MPH Family Medicine Residency of Idaho
Study Director: James Gardner, MD Saint Aphonsus Medical Group and Family Medicine Residency of Idaho Rural Training Track Director
Study Chair: Ted Epperly, MD Family Medicine Residency of Idaho
  More Information

Responsible Party: Family Medicine Residency of Idaho
ClinicalTrials.gov Identifier: NCT01839864     History of Changes
Other Study ID Numbers: FMRI Promotora Trial
Study First Received: April 18, 2013
Last Updated: February 13, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: No plan to share IPD as funding for the study was not successful so no recruiting occurred, thus, no IPD.

Keywords provided by Family Medicine Residency of Idaho:
Promotoras
Hispanic Adults
metabolic syndrome
rural
patient attitudes
provider cultural competency
patient activation measure

Additional relevant MeSH terms:
Syndrome
Metabolic Syndrome X
Disease
Pathologic Processes
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on August 16, 2017